Endpoints News is the biotech and pharmaceutical industry's most important source of daily news, and we're looking for a senior science correspondent who will be an authoritative voice on the biggest breakthroughs and failures, capture important trends in research and its intersection with business, and stitch together compelling narratives about science, patients and companies. The right candidate will be able to turn chemistry into character and can hold forth on the difference between tau and amyloid. They should have a network of research, academic and biopharma sources, and be as comfortable writing on deadline after a major clinical trial result as they are reporting a slow-burn feature. Our 150,000+ readers are made up of the scientists, executives, regulators and investors who drive the industry, and the right candidate will have the desire and ability to be a household name with that audience. You should have 7+ years of experience, an inspiring set of clips, and the ambition to be one of the stars of our newsroom. This post will report to our Deputy Editor for Reporting, and will work closely with our newsroom leaders as well as other reporters and editors throughout the company.